Visualization of Cathepsin Activity Using ProSense 680 Agent from Well to Cell to Animal
12 December 2012

In this application note, the cathepsin-activatable ProSense 680 near-infrared (NIR) imaging agent was assessed and validated for use throughout the drug discovery process, from biochemistry to cellular assays to in vivo testing, using HT-29 colorectal cancer cells and 5-Fluorouracil (5-FU) treatment. ProSense 680 was visualized in these studies using the Operetta® High Content Imaging System and FMT® 2500 Fluorescence Tomography In Vivo Imaging System. Using the same agent in translational studies ensures that biological interactions are comparable.

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!